HOME >> BIOLOGY >> NEWS
High-pressure Oxygen Therapy Could Offer Widespread Benefits

WASHINGTON, D.C. -- Hyperbaric oxygen therapy offers enough promise for treating victims of stroke and other debilitating traumas and diseases of the central nervous system to warrant in-depth scientific studies, a medical researcher said today.

Speaking at a meeting of the Space and Underwater Research Group of the World Federation of Neurology, Dr. Stephen Thom said that doctors do not have a clear understanding of why hyperbaric oxygen therapy works. Nonetheless, small-scale studies indicate that it may be useful, he said.

The meeting is being coordinated by the Stroke Research Center of the Wake Forest University Baptist Medical Center.

Hyperbaric oxygen therapy, or HBOT, refers to the practice of putting patients in pressure chambers and having them breathe pure oxygen at two or more times normal atmospheric pressure. HBOT significantly increases the amount of oxygen in the blood, and it is accepted treatment for carbon monoxide poisoning, decompression sickness, air embolism and certain other conditions.

But research to be presented at the meeting this week suggests that hyperbaric oxygen therapy could save millions or even billions of dollars annually in treating victims of stroke, epilepsy and spinal cord injury.

Particularly with respect to treating stroke, "There is potential for a meaningful benefit for patients," said Thom, president of the Undersea and Hyperbaric Medical Society.

The problem is, there's no reason why hyperbaric oxygen therapy should work. "There's a lot of data to say that if a blood vesssel is occluded (blocked), simply providing more oxygen to the blood is not going to help," Thom said. "There's no blood getting through so simply getting more oxygen in the blood is not getting more oxygen to the tissue.

"In fact, there are some theoretical arguements to suggest that giving more oxy
'"/>

Contact: Robert Conn
rconn@wfubmc.edu
336-716-4977
Wake Forest University Baptist Medical Center
11-May-1998


Page: 1 2

Related biology news :

1. Oxygen sensing in worms may hold key to healthy blood pressure in humans
2. Oxygen triggered the evolution of complex life forms
3. Oxygen deficiency is an endocrine disruptor in fish
4. Oxygen key switch in transforming adult stem cells from fat into cartilage
5. Evolution upset: Oxygen-making microbes came last, not first
6. Oxygen is toxic to stem cells
7. Oxygen measurements yield greenhouse clues
8. Tumor Oxygen Level And Blood Flow Fluctuate, Duke Scientists Discover
9. Fake Photosynthesis? Test-Tube System In Science Paper Sheds Light On The Oxygen We Breathe, UD Prof Says
10. Oxygen-Carrying Myoglobin Not Necessary For Survival
11. Stroke Risk Increased In Patients With High Oxygen Use In Brain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
Cached News: